Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study.
about
Asthma heterogeneity and severityAn American Thoracic Society/National Heart, Lung, and Blood Institute workshop report: addressing respiratory health equality in the United StatesImplications of population structure and ancestry on asthma genetic studies.Asthma pharmacogenetics and the development of genetic profiles for personalized medicinePharmacogenomics of long-acting β2-agonists.ADRB2 polymorphisms predict the risk of myocardial infarction and coronary artery diseaseChildhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment.Leveraging gene-environment interactions and endotypes for asthma gene discovery.Pharmacogenetics of beta2 adrenergic receptor agonists in asthma management.Do genetic polymorphisms alter patient response to inhaled bronchodilators?Influence of ethnicity on response to asthma drugs.Gene-Environment Interactions in Asthma: Genetic and Epigenetic Effects.The Effect of Ancestry and Genetic Variation on Lung Function Predictions: What Is "Normal" Lung Function in Diverse Human Populations?Asthma Pharmacogenomics: 2015 Update.Update in Asthma 2014.Pharmacogenetics and the treatment of asthma.Adenylyl Cyclase 9 Polymorphisms Reveal Potential Link to HDL Function and Cardiovascular Events in Multiple Pathologies: Potential Implications in Sickle Cell Disease.Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate + vilanterol for the treatment of asthma.Review on Pharmacogenetics and Pharmacogenomics Applied to the Study of Asthma.What Ancestry Can Tell Us About the Genetic Origins of Inter-Ethnic Differences in Asthma Expression.Effects of Aspergillus fumigatus on glucocorticoid receptor and β2-adrenergic receptor expression in a rat model of asthma.Effect of ADRB2 (adrenergic receptor β2) gene polymorphisms on the occurrence of asthma and on the response to nebulized salbutamol in South Indian patients with bronchial asthma.Treatment response heterogeneity in asthma: the role of genetic variation.Pharmacogenetic and pharmacogenomic considerations of asthma treatment.Predictive genetic profiles for β-agonist therapy in asthma. A future under construction.Increased Systemic Exposure and Stronger Cardiovascular and Metabolic Adverse Reactions to Fenoterol in Individuals with Heritable OCT1 Deficiency.AllerGAtlas 1.0: a human allergy-related genes database.Reciprocal modulation of helper Th1 and Th17 cells by the β2-adrenergic receptor agonist drug terbutaline.Management of Severe Asthma before Referral to the Severe Asthma Specialist.Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma.
P2860
Q28072301-F7CF0A57-1C10-4D0E-B348-F010E03B3EECQ32984871-EF774EFD-16A5-4A7B-BE62-34707603B46CQ34781489-80157EDB-1E2B-457E-9368-BBDA85165324Q35076452-6F201EE8-B4A4-464F-9A19-C70E95B39718Q35734012-D372793D-F843-4686-A014-62B19A9EEE06Q36606238-CA7BDEB5-A7DF-4E95-A6DA-D80850526BC3Q37062771-929A7C8D-08FF-4DE9-BEB6-AD9D632A5636Q37217123-3BA615FC-6D95-4D5F-B928-8F8A8D0ACEF4Q38196942-54C3F4F7-A05A-4A46-A22E-F5A52C43524AQ38237766-2FB8A051-4630-44DC-87BE-C7B83F8EB99BQ38494683-457E11F1-3FA4-49B0-8406-50B9F19A39F4Q38526092-6AD4FAC0-2D01-4AAD-934F-AA7A81301198Q38541189-6A8927FA-8184-4F93-B63F-FBBD9C2A37A1Q38542847-715EC264-8E78-41BC-9386-9FB8417DB541Q38547604-15B6725A-A0BB-4A97-9059-8CE05C24B922Q38646972-E1E141BC-AF25-4624-9D18-FF62E4FD6B98Q38653425-23A853D1-8AE6-4CB1-8E08-1B213E16F2F1Q38851423-3103D064-A1A2-4CC2-BF46-C900A639233DQ38853320-F0A083B6-FBE5-44D7-B61D-4801899342DAQ38890726-BD3B5EDA-4929-4937-AF22-6E1D845AC55DQ40139744-09252B7A-E9A2-4279-A152-541D12D21F2CQ41731430-B1B96921-70F6-4815-BDAB-6CEB1ABFE582Q47718997-CBDFC0D8-8DD4-40FB-9E28-3855F10A3DE6Q48220346-BD776B2D-2860-4309-8C62-025A087AA9FBQ48583659-A9630856-52F9-4E04-8EED-27B70CC39C59Q48743258-6F36CE58-EE53-40A4-A368-5998C8CDEA60Q50333965-B7EC3010-F0D4-4CE7-B1D1-D1182C5FCF93Q50889421-C0CF2AD8-024D-4B80-B019-8435B9FFF602Q52583301-B12B0DC5-C8BB-4687-ABA3-5D37BF6FC6FAQ53620614-142B1C25-1D35-4888-9C6A-98156F0FD428
P2860
Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Effect of rare variants in ADR ...... a population: a genetic study.
@ast
Effect of rare variants in ADR ...... a population: a genetic study.
@en
type
label
Effect of rare variants in ADR ...... a population: a genetic study.
@ast
Effect of rare variants in ADR ...... a population: a genetic study.
@en
prefLabel
Effect of rare variants in ADR ...... a population: a genetic study.
@ast
Effect of rare variants in ADR ...... a population: a genetic study.
@en
P2093
P2860
P1476
Effect of rare variants in ADR ...... a population: a genetic study.
@en
P2093
Annette T Hastie
Deborah A Meyers
Domingo Chardon
Elizabeth J Ampleford
Elliot Israel
Federico Montealegre
Gregory A Hawkins
Mario Castro
Sally E Wenzel
Serpil C Erzurum
P2860
P304
P356
10.1016/S2213-2600(13)70289-3
P577
2014-01-27T00:00:00Z